Gore Hybrid Vascular Graft Allows for Access to Deeper Vessels
W. L. Gore and Associates' new 10-cm configuration of the Gore Hybrid Vascular Graft allows for access to deeper vessels, which expands the treatable patient population and offers exceptional ease of use for physicians performing vascular procedures.
The Gore Hybrid Vascular Graft is indicated for use as a vascular prosthesis for replacement or bypass of diseased vessels in patients suffering occlusive or aneurysmal diseases, in trauma patients requiring vascular replacement, for dialysis access or for other vascular procedures.
The new configuration features a 10 cm durable Nitinol Reinforced Section that is double the length of the existing 5 cm Gore Hybrid Vascular Graft. The longer extension allows physicians to access even deeper vessels and create new access sites in anatomical locations that would have otherwise been abandoned, preserving the number of access sites available throughout a patient’s long-term therapy.
As with the original Gore Hybrid Vascular Graft, the 10 cm configuration is highly versatile, providing a streamlined solution for several critical vascular procedures.
The Gore Hybrid Vascular Graft combines several trusted Gore technologies. The expanded polytetrafluoroethylene (ePTFE) vascular prosthesis has a section reinforced with nitinol, which is partially constrained to allow for easy insertion and deployment into vessels that are difficult to reach or in challenging anatomical locations. It is the only combination graft of its kind that incorporates Carmeda BioActive Surface (CBAS Surface) with covalently bonded heparin, resulting in a proven thromboresistant surface.
The Gore Hybrid Vascular Graft was launched in the United States in May 2011 and in Europe in August 2012. It was recently named the Gold Winner in the Implant and Tissue-Replacement Products category of the 2012 Medical Design Excellence Awards. Since commercialization, more than 3,000 successful implants for dialysis access and other vascular procedures have been recorded.
For more information: www.goremedical.com